Memantine vs placebo
Adverse events · people with Down syndrome
Comparison 2: memantine showed no clear difference in adverse events compared with placebo (low certainty).
1 finding from 1 review
- Pharmacological interventions for cognitive decline in people with Down syndrome 2015 · Cochrane Headline outcomes onlyOR 0.45 [0.18, 1.17]2 studies · 211 participantsLow